Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal vesicle trafficking-associated protein 2 (NSG2) is a small type II transmembrane protein predominantly expressed in neurons, especially in the brain and Golgi apparatus. NSG2 is endocytosed from the neuronal cell surface, traffics through early and late endosomes, and is then rapidly degraded in lysosomes with a half-life under two hours. It partially co-localizes with neuronal endosomal markers and has been implicated in regulating membrane trafficking, including the postsynaptic distribution of neurotransmitter receptors. NSG2 is predicted to bind clathrin light chains and participate in clathrin coat assembly and endosomal transport. The gene is genetically linked to rare forms of ataxia but is currently not directly implicated in common neurodegenerative or neuropsychiatric conditions. NSG2 is poorly studied and not considered a classical drug target such as a receptor or transporter; its function appears to involve neuronal membrane protein homeostasis and degradative trafficking, rather than serving as a signaling receiver or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal vesicle trafficking-associated protein 2 (NSG2).